HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the sale, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Frank Corvino also recently made the following trade(s):
- On Monday, July 8th, Frank Corvino sold 7,705 shares of HealthEquity stock. The shares were sold at an average price of $81.89, for a total value of $630,962.45.
HealthEquity Trading Down 1.2 %
Shares of NASDAQ:HQY traded down $0.92 during mid-day trading on Thursday, hitting $78.18. The company had a trading volume of 567,760 shares, compared to its average volume of 621,584. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a one year low of $61.81 and a one year high of $88.26. The firm has a fifty day moving average price of $76.46 and a 200 day moving average price of $79.20. The company has a market capitalization of $6.80 billion, a PE ratio of 85.40, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52.
Institutional Investors Weigh In On HealthEquity
Hedge funds and other institutional investors have recently modified their holdings of the company. Forest Hill Capital LLC bought a new stake in HealthEquity during the 4th quarter valued at $2,021,000. Vanguard Group Inc. lifted its position in HealthEquity by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after acquiring an additional 149,133 shares in the last quarter. Diversify Advisory Services LLC acquired a new position in HealthEquity during the 1st quarter valued at about $7,828,000. Vaughan Nelson Investment Management L.P. bought a new stake in HealthEquity during the 1st quarter worth approximately $49,443,000. Finally, Lisanti Capital Growth LLC purchased a new stake in shares of HealthEquity in the first quarter worth approximately $4,701,000. Institutional investors own 99.55% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on HQY. Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. JMP Securities reiterated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Royal Bank of Canada reissued an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America dropped their target price on HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, September 4th. Finally, Raymond James boosted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $103.83.
Read Our Latest Stock Analysis on HQY
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Financial Services Stocks Investing
- When Is the Best Time to Invest in Mutual Funds?
- Most active stocks: Dollar volume vs share volume
- Is NVIDIA Stock in a Correction or Consolidation?
- Insider Trading – What You Need to Know
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.